Exopharm set to acquire Tryp Therapeutics
SYDNEY, AUSTRALIA: , Exopharm Limited has announced an agreement to acquire all issued capital of Tryp Therapeutics Inc. through a Canadian plan of arrangement. The deal will see Tryp shareholders receive 3.616 Exopharm shares for each Tryp share held, marking…